Table 2: Alloantibody specificity and frequency in 116 Palestinian SCD patients.

Alloantibody specificityFrequency and percentage of alloantibody, n (%)

Anti-K3 (33.3%)

Anti-E2 (22.2%)

Anti-D1 (11.1%)

Anti-C1 (11.1%)

Anti-c1 (11.1%)

Anti-D, -C1 (11.1%)

Total9 (100%)